| BRPF1 |
BRPF1, BR140: Peregrin |
H1FX |
H1FX: Histone H1x |
0.36 |
Evidence |
|
| BRPF1 |
BRPF1, BR140: Peregrin |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
0.36 |
Evidence |
|
| YARS |
YARS: Tyrosyl-tRNA synthetase, cytoplasmic |
TOP2A |
TOP2A, TOP2: DNA topoisomerase 2-alpha |
0.36 |
Evidence |
|
| TERF1 |
TERF1, PIN2, TRBF1, TRF, TRF1: Telomeric repeat-binding factor 1 |
SPEN |
SPEN, KIAA0929, MINT, SHARP: Msx2-interacting protein |
0.36 |
Evidence |
|
| TERF1 |
TERF1, PIN2, TRBF1, TRF, TRF1: Telomeric repeat-binding factor 1 |
RBM15 |
RBM15, OTT: Putative RNA-binding protein 15 |
0.36 |
Evidence |
|
| TERF1 |
TERF1, PIN2, TRBF1, TRF, TRF1: Telomeric repeat-binding factor 1 |
PHF3 |
PHF3, KIAA0244: PHD finger protein 3 |
0.36 |
Evidence |
|
| BLM |
BLM, RECQ2, RECQL3: Bloom syndrome protein |
TERF2 |
TERF2, TRBF2, TRF2: Telomeric repeat-binding factor 2 |
0.36 |
Evidence |
|
| LIMK2 |
LIMK2: LIM domain kinase 2 |
MICAL-L1 |
MICALL1, KIAA1668, MIRAB13: MICAL-like protein 1 |
0.36 |
Evidence |
|
| CTSC |
CTSC, CPPI: Dipeptidyl-peptidase 1 precursor |
CTSZ |
CTSZ: Cathepsin Z precursor |
0.36 |
Evidence |
|
| MSH6 |
MSH6, GTBP: DNA mismatch repair protein MSH6 |
TP53BP1 |
TP53BP1: Tumor suppressor p53-binding protein 1 |
0.36 |
Evidence |
|
| INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
MAP3K10 |
MAP3K10, MLK2, MST: Mitogen-activated protein kinase kinase kinase 10 |
0.36 |
Evidence |
|
| INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
0.36 |
Evidence |
|
| LUM |
LUM, LDC: Lumican precursor |
ADAMTS1 |
ADAMTS1, KIAA1346, METH1: ADAMTS-1 precursor |
0.36 |
Evidence |
|
| RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
CRLF3 |
IPI00295387 |
0.36 |
Evidence |
|
| STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
PASK |
PASK, KIAA0135: PAS domain-containing serine/threonine-protein kinase |
0.36 |
Evidence |
|
| STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
IRF3 |
IRF3: Interferon regulatory factor 3 |
0.36 |
Evidence |
|
| CCL11 |
CCL11, SCYA11: Eotaxin precursor |
FSTL1 |
FSTL1, FRP: Follistatin-related protein 1 precursor |
0.36 |
Evidence |
|
| IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
TRIM28 |
TRIM28, KAP1, RNF96, TIF1B: Transcription intermediary factor 1-beta |
0.36 |
Evidence |
|
| IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
0.36 |
Evidence |
|
| MECP2 |
MECP2: Methyl-CpG-binding protein 2 |
TERF2 |
TERF2, TRBF2, TRF2: Telomeric repeat-binding factor 2 |
0.36 |
Evidence |
|
| BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
ATAD2 |
ATAD2, L16, PRO2000: ATPase family AAA domain-containing protein 2 |
0.36 |
Evidence |
|
| BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
TRIP13 |
TRIP13: Thyroid receptor-interacting protein 13 |
0.36 |
Evidence |
|
| BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
ORC1L |
ORC1L, ORC1, PARC1: Origin recognition complex subunit 1 |
0.36 |
Evidence |
|
| SMARCA4 |
SMARCA4, BRG1, SNF2B, SNF2L4: Probable global transcription activator SNF2L4 |
PIP5K3 |
PIP5K3, KIAA0981, PIKFYVE: FYVE finger-containing phosphoinositide kinase |
0.36 |
Evidence |
|
| SMARCA4 |
SMARCA4, BRG1, SNF2B, SNF2L4: Probable global transcription activator SNF2L4 |
TGIF2 |
TGIF2: Homeobox protein TGIF2 |
0.36 |
Evidence |
|